Recent Updates
Recently added Catalysts
UTHR Positive Sentiment

United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting

Tuesday, October 13, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: United Therapeutics Corporation announced its participation in the CHEST 2026 Annual Meeting, where it will present two oral and five poster presentations. The event, hosted by the American College of Chest Physicians, will take place from October 18-21, 2026, in Phoenix, Arizona. The company aims to highlight its commercial and development portfolio.

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation of new data at a major conference.
  • Engagement with the medical community through sponsorship.
  • Diverse portfolio showcased through multiple presentations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+83%
120-day peak, hindsight
Typical move
6.5%
average across 6 past catalysts
Lead asset
APD811
NDA/BLA · Pulmonary Arterial Hypertension

Full Press Release Details

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that two oral and five poster presentations will be presented across its commercial and development portfolio at the CHEST 2026 Annual Meeting hosted by the American College of Chest Physicians taking place October 18-21, 2026, in Phoenix, Arizona. United Therapeutics will also sponsor and host Time to Look Closer: Emerging Data and Sc

Frequently Asked Questions

What will United Therapeutics present at CHEST 2026?

United Therapeutics will present two oral and five poster presentations.

When is the CHEST 2026 Annual Meeting?

The CHEST 2026 Annual Meeting will take place from October 18-21, 2026.

Where is the CHEST 2026 Annual Meeting held?

The meeting will be held in Phoenix, Arizona.

Who hosts the CHEST 2026 Annual Meeting?

The meeting is hosted by the American College of Chest Physicians.

ShareAdd on Google
Tags: UTHR United Therapeutics CHEST 2026 clinical data Phoenix medical conference
Last updated: Oct 13, 2026

Biotech snapshot

Cash runway
$3803M liquidity · $0M/mo burn
Low dilution risk
Lead asset
APD811NDA/BLA
Pulmonary Arterial Hypertension →

Catalyst track record

+83%
best trade around UTHR's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for UTHR.

See every catalyst's timing & PoA →